Stonepine reports 1.74M shares (9.9%) of Azitra
Azitra, Inc. ownership disclosure: Stonepine entities and Jon M. Plexico report shared beneficial ownership of 1,744,339 shares of Common Stock, representing 9.9% of the class.
Rhea-AI Filing Summary
Azitra, Inc. ownership disclosure: Stonepine entities and Jon M. Plexico report shared beneficial ownership of 1,744,339 shares of Common Stock, representing 9.9% of the class. The filing states the percentage "is giving effect to the 9.99% beneficial ownership limitation" and uses May 12, 2026 as the outstanding-share anchor of 16,192,438 shares.
The reporting persons note their holdings comprise 475,923 shares of Common Stock, Series A Preferred convertible into 27,107,210 shares, and Warrants to acquire 54,214,420 shares, each subject to a 9.99% beneficial ownership cap. Signatures show Jon M. Plexico as the reporting signatory.
Positive
- None.
Negative
- None.
Insights
Stonepine and related parties report a near-10% aggregated stake under a beneficial-ownership cap.
The filing lists shared voting and dispositive power over 1,744,339 shares, recorded as 9.9% of outstanding common stock based on May 12, 2026 and an outstanding base of 16,192,438 shares. It expressly references a 9.99% beneficial ownership limitation applied to convertible Series A Preferred and Warrants.
Key dependencies include the applicability of the 9.99% cap and the conversion/exercise mechanics; subsequent schedules or amendments could change the reported percentage if conversions/exercises occur or if the outstanding share base changes.
The position combines direct common shares plus convertible and warrant exposure capped at 9.99%.
The disclosure itemizes 475,923 common shares, Series A Preferred convertible into 27,107,210 shares, and Warrants exercisable into 54,214,420 shares, with the combined conversion/exercise quantities subject to a 9.99% beneficial ownership limitation. The reported 1,744,339-share figure reflects the cap's effect in the calculation methodology.
Cash‑flow treatment and exact conversion/exercise pricing are not stated in the excerpt; future filings could specify timing, prices, or mechanics that affect potential dilution and actual ownership levels.
Key Figures
Key Terms
9.99% beneficial ownership limitation regulatory
Series A Preferred financial
Warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Stonepine report in Azitra (AZTR)?
How did the filing calculate the 9.9% ownership for AZTR?
What convertible and warrant exposure do the reporting persons disclose?
Who signed the Schedule 13G for AZTR and in what capacity?
Does the Schedule 13G show sole voting or dispositive power for the reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.